Genetic Polymorphism of CYP2D6 and MDR1 in breast cancer patients treated with tamoxifen
Introduction: Tamoxifen is the drug of choice for the treatment of breast cancer patients who are positive for estrogen receptor. It is metabolized by Cytochrome P450 2D6 (CYP2D6) and the variations in CYP2D6 activity has been reported to have important therapeutic consequences which include develop...
| Main Authors: | , , , , |
|---|---|
| Format: | Conference or Workshop Item |
| Language: | English |
| Published: |
2010
|
| Subjects: | |
| Online Access: | http://irep.iium.edu.my/5238/ http://irep.iium.edu.my/5238/1/Abstract_CYP2D6_NNCC.pdf |